Low hemoglobin predicts high‐platelet reactivity and major cardiovascular ischemic events at long‐term follow‐up among ACS patients receiving dual antiplatelet therapy with ticagrelor-Reference-Cited by-同舟云学术

Low hemoglobin predicts high‐platelet reactivity and major cardiovascular ischemic events at long‐term follow‐up among ACS patients receiving dual antiplatelet therapy with ticagrelor

Published:2021-02 Issue:7 Volume:98 Page:1309-1316
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Verdoia Monica¹²^ORCID,Rolla Roberta³,Pergolini Patrizia³,Gioscia Rocco⁴,Nardin Matteo²,Negro Federica²,Viglione Filippo²⁴,Suryapranata Harry⁵,Kedhi Elvin⁶,De Luca Giuseppe²⁴,

Affiliation:

1. Division of Cardiology Ospedale degli Infermi Biella Italy

2. Department of Translational Medicine Eastern Piedmont University Novara Italy

3. Clinical Chemistry, Azienda Ospedaliera‐Universitaria “Maggiore della Carità” Eastern Piedmont University Novara Italy

4. Azienda Ospedaliera‐Universitaria “Maggiore della Carità” Eastern Piedmont University Novara Italy

5. Department of Cardiology UMC St Radboud Nijmegen The Netherlands

6. Department of Cardiology ISALA Hospital Zwolle The Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29512

Reference41 articles.

1. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2. Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low‐Dose Prasugrel or Clopidogrel

3. Very short dual antiplatelet therapy after PCI and new DES: a meta‐analysis of 5 randomized trials;Verdoia M;Rev Esp Cardiol (Engl Ed),2020

4. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

5. Ticagrelor with or without Aspirin in High-Risk Patients after PCI

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study;BMC Neurology;2024-06-24

2. Comparison of ticagrelor and clopidogrel in anemic patients with acute coronary syndrome: efficacy and safety outcomes over one year;European Journal of Clinical Pharmacology;2024-02-16

3. Effect of Ticagrelor or Clopidogrel Treatment on 1-Year Cardiovascular Outcomes in Anemic Patients with Acute Coronary Syndrome;2023-10-06

4. Association of ADP-Induced Whole-Blood Platelet Aggregation with Serum Low-Density Lipoprotein Cholesterol in Patients with Coronary Artery Disease When Receiving Maintenance Ticagrelor-Based Dual Antiplatelet Therapy;Journal of Clinical Medicine;2023-07-06

5. A HANC Risk Stratification Score for Antiplatelet Therapy Optimization with Low-Dose Prasugrel in Taiwanese Acute Coronary Syndrome Patients from the Switch Study;ACTA CARDIOL SIN;2022